Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/155835Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Al-kuraishy, HM | |
| dc.creator | Al-Gareeb, AI | |
| dc.creator | Abdullah, SM | |
| dc.creator | Martins, N | |
| dc.creator | Batiha, GES | |
| dc.date.accessioned | 2023-12-15T12:31:23Z | - |
| dc.date.available | 2023-12-15T12:31:23Z | - |
| dc.date.issued | 2021 | |
| dc.identifier.issn | 2297-055X | |
| dc.identifier.uri | https://hdl.handle.net/10216/155835 | - |
| dc.description.abstract | Gilbert syndrome (GS) is a liver disorder characterized by non-hemolytic unconjugated hyperbilirubinemia. On the other hand, Coronavirus disease 2019 (Covid-19) is a recent viral infectious disease presented as clusters of pneumonia, triggered by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). Little is known on the association between SARS-CoV-2 and GS, despite different studies have recently stated a link between hyperbilirubinemia and SARS-CoV-2 severity. In this case-report study we described a 47-year-old man, a known case of GS since the age of 4, presented to the emergency department with fever (39.8°C), dry cough, dyspnea, headache, myalgia, sweating and jaundice diagnosed with Covid-19-induced pneumonia. Interestingly, GS patient exhibited a rapid clinical recovery and short hospital stay compared to other SARS-CoV-2 positive patient, seeming that hyperbilirubinemia may exert a protective effect of against Covid-19 induced-cardiometabolic disturbances. Data obtained here underlines that the higher resistance against Covid-19 evidenced by the GS patient seems to be due to the antioxidant, anti-inflammatory, and antiviral effects of unconjugated bilirubin. | |
| dc.description.sponsorship | To all members in College of Medicine, Al-Mustansiyria University. NC-M acknowledges the Portuguese Foundation for Science and Technology under the Horizon 2020 Program (PTDC/PSI-GER/28076/2017). | |
| dc.language.iso | eng | |
| dc.publisher | Frontiers Media | |
| dc.relation | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FPSI-GER%2F28076%2F2017/PT | |
| dc.relation.ispartof | Frontiers in Cardiovascular Medicine, vol.8:642181 | |
| dc.rights | openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | COVID-19 | |
| dc.subject | Gilbert syndrome | |
| dc.subject | Hyperbilirubinemia | |
| dc.subject | Metabolic disease | |
| dc.subject | SARS-CoV-2 | |
| dc.title | Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances | |
| dc.type | Artigo em Revista Científica Internacional | |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | |
| dc.identifier.doi | 10.3389/fcvm.2021.642181 | |
| dc.relation.publisherversion | https://www.frontiersin.org/articles/10.3389/fcvm.2021.642181/full | |
| Appears in Collections: | I3S - Artigo em Revista Científica Internacional | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 10.3389-fcvm.2021.642181.pdf | 360.81 kB | Adobe PDF | ![]() View/Open |
This item is licensed under a Creative Commons License
